Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Cancer Gene Therapy|October 10, 2019
A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.Molecular Therapy. Nucleic Acids|August 11, 2019
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer CellsYue Han, Chengyu Wang, Qi Dong, et al.Journal of Molecular Medicine (Berlin, Germany)|November 11, 2022
Identification of mutational signature for lung adenocarcinoma prognosis and immunotherapy predictionSainan Zhang, Mengyue Li, Yilong Tan, et al.Journal of Translational Medicine|January 16, 2020
Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinomaYing Li, Wenbin Jiang, Tianhao Li, et al.FEBS Letters|December 2, 2021
Pan-cancer multi-omics analyses reveal crosstalk between the Hippo and immune signaling pathways in the tumor microenvironmentChengyu Wang, Tong Zhu, Zhangxiang Zhao, et al.Journal of Molecular Medicine (Berlin, Germany)|January 21, 2016
miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPFHaihai Liang, Shanshan Liu, Yang Chen, et al.Oncotarget|March 12, 2016
A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sourcesWenyuan Zhao, Beibei Chen, Xin Guo, et al.Briefings in Bioinformatics|January 19, 2017
A landscape of synthetic viable interactions in cancerYunyan Gu, Ruiping Wang, Yue Han, et al.Molecular Therapy. Nucleic Acids|November 17, 2021
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual levelShuping Zhuang, Tingting Chen, Yawei Li, et al.Aging|July 9, 2020
An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression orderingTingting Chen, Zhangxiang Zhao, Bo Chen, et al.Pageof 9